Possible role of BMP‑4 in the hyper‑pigmentation of psoriatic plaques after anti‑TNF‑α treatment

Lowes MA, Suárez-Fariñas M and Krueger JG: Immunology of psoriasis. Annu Rev Immunol. 32:227–255. 2014. View Article : Google Scholar : PubMed/NCBI

Balato A, Scala E, Balato N, Caiazzo G, Di Caprio R, Monfrecola G, Raimondo A, Lembo S and Ayala F: Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders. Expert Opin Biol Ther. 17:1363–1374. 2017.PubMed/NCBI

Caiazzo G, Fabbrocini G, Di Caprio R, Raimondo A, Scala E, Balato N and Balato A: Psoriasis, cardiovascular events and biologics: Lights and shadows. Front Immunol. 9:16682018. View Article : Google Scholar : PubMed/NCBI

Swope VB, Abdel-Malek Z, Kassem LM and Nordlund JJ: Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol. 96:180–185. 1991. View Article : Google Scholar : PubMed/NCBI

Balato N, Di Costanzo L, Balato A, Patruno C, Scalvenzi M and Ayala F: Psoriasis and melanocytic naevi: Does the first confer a protective role against melanocyte progression to naevi? Br J Dermatol. 164:1262–1270. 2011. View Article : Google Scholar : PubMed/NCBI

Cichorek M, Wachulska M, Stasiewicz A and Tymińska A: Skin melanocytes: Biology and development. Postepy Dermatol Alergol. 30:30–41. 2013. View Article : Google Scholar : PubMed/NCBI

Wang CQF, Akalu YT, Suarez-Farinas M, Gonzalez J, Mitsui H, Lowes MA, Orlow SJ, Manga P and Krueger JG: IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: Potential relevance to psoriasis. J Invest Dermatol. 133:2741–2752. 2013. View Article : Google Scholar : PubMed/NCBI

Di Cesare A, Fargnoli MC, Marinucci A and Peris K: Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents. J Invest Dermatol. 135:318–320. 2015. View Article : Google Scholar : PubMed/NCBI

Kim M and Choe S: BMPs and their clinical potentials. BMB Rep. 44:619–634. 2011. View Article : Google Scholar : PubMed/NCBI

Singh SK, Abbas WA and Tobin DJ: Bone morphogenetic proteins differentially regulate pigmentation in human skin cells. J Cell Sci. 125:4306–4319. 2012. View Article : Google Scholar : PubMed/NCBI

Blessing M, Schirmacher P and Kaiser S: Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: Inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol. 135:227–239. 1996. View Article : Google Scholar : PubMed/NCBI

Bilodeau ML, Greulich JD, Hullinger RL, Bertolotto C, Ballotti R and Andrisani OM: BMP-2 stimulates tyrosinase gene expression and melanogenesis in differentiated melanocytes. Pigment Cell Res. 14:328–326. 2001. View Article : Google Scholar : PubMed/NCBI

Yaar M, Wu C, Park HY, Panova I, Schutz G and Gilchrest BA: Bone morphogenetic protein-4, a novel modulator of melanogenesis. J Biol Chem. 281:25307–25314. 2006. View Article : Google Scholar : PubMed/NCBI

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

Schmittgen TD and Zakrajsek BA: Effect of experimental treatment on housekeeping gene expression: Validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods. 46:69–81. 2000. View Article : Google Scholar : PubMed/NCBI